Get started
AAREY DRUGS & PHARM LTDAAREY DRUGS & PHARM LTDAAREY DRUGS & PHARM LTD

AAREY DRUGS & PHARM LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

AAREYDRUGS chart


Full chart

AAREYDRUGS upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.78 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
28.19
Basic EPS (TTM)
2.27 INR
Net income (FY)
‪46.84 M‬ INR
Revenue (FY)
‪3.95 B‬ INR
Shares float
—
Beta (1Y)
1.09

About AAREY DRUGS & PHARM LTD


Sector
Health Technology
CEO
Mihir Rajesh Ghatalia
Headquarters
Mumbai
Website
aareydrugs.com
Founded
1990
ISIN
INE198H01019
FIGI
BBG000D2FKB7
Aarey Drugs & Pharmaceuticals Ltd. engages in the trade and manufacture of pharmaceutical ingredients, drug intermediates, specialty chemicals, industrial solvents, and chemicals. Its products include mono methyl urea, dimethyl urea, theobromine, theophylline, mefanamic acid, bromomethyl, and dioxolane. The company was founded by Rajesh Pranlal Ghatalia on May 15, 1990 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AAREYDRUGS news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AAREYDRUGS is 64.00 INR — it has increased by 0.03% in the past 24 hours. Watch AAREY DRUGS & PHARM LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange AAREY DRUGS & PHARM LTD stocks are traded under the ticker AAREYDRUGS.
AAREYDRUGS stock has risen by 3.56% compared to the previous week, the month change is a 4.03% rise, over the last year AAREY DRUGS & PHARM LTD has showed a 23.55% increase.
AAREYDRUGS reached its all-time high on Sep 5, 2024 with the price of 74.80 INR, and its all-time low was 22.00 INR and was reached on Mar 27, 2023. View more price dynamics on AAREYDRUGS chart.
See other stocks reaching their highest and lowest prices.
AAREYDRUGS stock is 3.20% volatile and has beta coefficient of 1.09. Track AAREY DRUGS & PHARM LTD stock price on the chart and check out the list of the most volatile stocks — is AAREY DRUGS & PHARM LTD there?
Today AAREY DRUGS & PHARM LTD has the market capitalization of ‪1.78 B‬, it has decreased by −1.02% over the last week.
Yes, you can track AAREY DRUGS & PHARM LTD financials in yearly and quarterly reports right on TradingView.
AAREY DRUGS & PHARM LTD is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
AAREYDRUGS net income for the last quarter is ‪12.39 M‬ INR, while the quarter before that showed ‪21.52 M‬ INR of net income which accounts for −42.42% change. Track more AAREY DRUGS & PHARM LTD financial stats to get the full picture.
AAREY DRUGS & PHARM LTD dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AAREY DRUGS & PHARM LTD EBITDA is ‪42.91 M‬ INR, and current EBITDA margin is 2.41%. See more stats in AAREY DRUGS & PHARM LTD financial statements.
Like other stocks, AAREYDRUGS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AAREY DRUGS & PHARM LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AAREY DRUGS & PHARM LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AAREY DRUGS & PHARM LTD stock shows the buy signal. See more of AAREY DRUGS & PHARM LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.